Extremely low frequency electromagnetic stimulation reduces ischemic stroke volume by improving central collateral blood flow

Autor: Kemps, Hannelore, Dessy, Chantal, Dumas, Laurent, Sonveaux, Pierre, Alders, Lotte, Van Broekhoven, Jana, Perez Font, Lena, Lambrichts, Sara, Foulquier, Sebastien, Hendrix, Sven, Brone, Bert, Lemmens, Robin, Bronckaers, Annelies

Publikováno v: Journal of Cerebral Blood Flow and Metabolism, Vol. 42, no. 6, p. 979-996 (2022)

Extremely low frequency electromagnetic stimulation (ELF-EMS) has been considered as a neuroprotective therapy for ischemic stroke based on its capacity to induce nitric oxide (NO) signaling. Here, we examined whether ELF-EMS reduces ischemic stroke

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1493::1f4f616dcf6e14521640d36448938f36
https://hdl.handle.net/2078.1/258143

Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue

Autor: PONSAERTS, Laura, ALDERS, Lotte, SCHEPERS, Melissa, de Oliveira, RMW, Prickaerts, J, VANMIERLO, Tim, BRONCKAERS, Annelies

Ischemic stroke is caused by a thromboembolic occlusion of a major cerebral artery, with the impaired blood flow triggering neuroinflammation and subsequent neuronal damage. Both the innate immune system (e.g., neutrophils, monocytes/macrophages) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______105::2839e868b0043c9ddfe1cebd58ba4960
http://hdl.handle.net/1942/36103

Extremely low frequency electromagnetic stimulation reduces ischemic stroke volume by improving cerebral collateral blood flow.

Autor: Kemps H; Biomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium., Dessy C; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium., Dumas L; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium., Sonveaux P; Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain (UCLouvain), Brussels, Belgium., Alders L; Biomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium., Van Broeckhoven J; Biomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium., Font LP; Centro Nacional de Electromagnetismo Aplicado (CNEA), Universidad de Oriente, Santiago de Cuba, Cuba., Lambrichts S; Department of Pharmacology and Toxicology, School for Mental Health and Neuroscience, Maastricht University Medical Center+, Maastricht, The Netherlands., Foulquier S; Department of Pharmacology and Toxicology, School for Mental Health and Neuroscience, Maastricht University Medical Center+, Maastricht, The Netherlands.; CARIM, School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands., Hendrix S; Biomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.; Medical School Hamburg, Hamburg, Germany., Brône B; Biomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium., Lemmens R; KU Leuven, - University of Leuven, Department of Neurosciences, Experimental Neurology, Leuven, Belgium.; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium.; Department of Neurology, University Hospitals Leuven, Leuven, Belgium., Bronckaers A; Biomedical Research Institute (BIOMED), Hasselt University (UHasselt), Diepenbeek, Belgium.

Publikováno v: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2022 Jun; Vol. 42 (6), pp. 979-996. Date of Electronic Publication: 2022 Feb 25.